TOLAK DIN 02485346
Health Canada record
| Active ingredient(s) | FLUOROURACIL (FLUOROURACIL SODIUM) 4 % |
|---|---|
| Dosage form | Cream |
| Route | Topical |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | L01BC02 FLUOROURACIL |
| Original market date | 25-Jun-2019 |
| Current status date | 25-Jun-2019 |
| Source | Health Canada DPD |
Establishment licence of the holder
Hill Dermaceuticals Inc. — licence 100374, currently licensed, last inspection rating C (2022-08-31).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 21816 | 2019-02-01 | New Drug Submission (NDS) |